ArticleEvidence-based complementary and alternative medicine : eCAM2014

KCHO-1, a Novel Antineuroinflammatory Agent, Inhibits Lipopolysaccharide-Induced Neuroinflammatory Responses through Nrf2-Mediated Heme Oxygenase-1 Expression in Mouse BV2 Microglia Cells.

Dong-Sung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.